CCMH
LAB icon

Cornerstone Capital Management Holdings’s Standard BioTools LAB Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,900
Closed -$24K – 1276
2017
Q3 		$24K Sell
4,900
-12,600
-72% -$53K ﹤0.01% 1236
2017
Q2 		$70K Buy
+17,500
New +$83K ﹤0.01% 1212

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cornerstone Capital Management Holdings's LAB Position: Q4 2017 in Review

Cornerstone Capital Management Holdings sold out of Standard BioTools (LAB) in Q4 2017, closing a stake of 4,900 shares — an estimated $24K sold.

Cornerstone Capital Management Holdings first reported a position in LAB in Q2 2017 and held it in 2 quarters. The position peaked at $70K in Q2 2017. 81 funds tracked by Wall St. Rank hold LAB as of Q4 2017.

  • Cornerstone Capital Management Holdings reported no remaining Standard BioTools position as of Q4 2017 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 4,900 Standard BioTools shares in Q4 2017, an estimated $24K.
  • Cornerstone Capital Management Holdings first reported a position in Standard BioTools in Q2 2017 and held it in 2 quarters.
  • Cornerstone Capital Management Holdings's Standard BioTools position peaked at $70K in Q2 2017.
  • 81 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.